[go: up one dir, main page]

WO2006105741A3 - Topical pharmaceutical formulation containing nimesulide - Google Patents

Topical pharmaceutical formulation containing nimesulide Download PDF

Info

Publication number
WO2006105741A3
WO2006105741A3 PCT/CZ2006/000016 CZ2006000016W WO2006105741A3 WO 2006105741 A3 WO2006105741 A3 WO 2006105741A3 CZ 2006000016 W CZ2006000016 W CZ 2006000016W WO 2006105741 A3 WO2006105741 A3 WO 2006105741A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical formulation
formulation containing
topical pharmaceutical
containing nimesulide
nimesulide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CZ2006/000016
Other languages
French (fr)
Other versions
WO2006105741A2 (en
WO2006105741B1 (en
Inventor
Jitka Fortova
Zdenka Mrvova
Pavlina Kristenova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva KS
Original Assignee
Zentiva KS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva KS filed Critical Zentiva KS
Priority to EA200702171A priority Critical patent/EA200702171A1/en
Priority to EP06705758A priority patent/EP1879565A2/en
Publication of WO2006105741A2 publication Critical patent/WO2006105741A2/en
Publication of WO2006105741A3 publication Critical patent/WO2006105741A3/en
Publication of WO2006105741B1 publication Critical patent/WO2006105741B1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The topical pharmaceutical formulation containing nimesulide contains a hydration agent, preferably propyleneglycol, a non-ionic surface-active substance and optionally other pharmaceutically acceptable additives.
PCT/CZ2006/000016 2005-04-06 2006-04-06 Topical pharmaceutical formulation containing nimesulide Ceased WO2006105741A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EA200702171A EA200702171A1 (en) 2005-04-06 2006-04-06 PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING NIMESULIDE
EP06705758A EP1879565A2 (en) 2005-04-06 2006-04-06 Topical pharmaceutical formulation containing nimesulide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZPV214-05 2005-04-06
CZ20050214A CZ297215B6 (en) 2005-04-06 2005-04-06 Topical medicamentous form containing nimesulide

Publications (3)

Publication Number Publication Date
WO2006105741A2 WO2006105741A2 (en) 2006-10-12
WO2006105741A3 true WO2006105741A3 (en) 2007-03-08
WO2006105741B1 WO2006105741B1 (en) 2007-04-19

Family

ID=37073817

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CZ2006/000016 Ceased WO2006105741A2 (en) 2005-04-06 2006-04-06 Topical pharmaceutical formulation containing nimesulide

Country Status (4)

Country Link
EP (1) EP1879565A2 (en)
CZ (1) CZ297215B6 (en)
EA (1) EA200702171A1 (en)
WO (1) WO2006105741A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110056516A (en) * 2008-09-12 2011-05-30 크리티컬 파머수티컬스 리미티드 Improved absorption of therapeutics through mucous membranes or skin
KR102086316B1 (en) * 2019-09-09 2020-03-09 한국콜마주식회사 Cosmetic composition having excellent percutaneous absorption property

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782855A1 (en) * 1994-10-05 1997-07-09 Helsinn Healthcare S.A. Antiinflammatory agent for external use
WO2000009117A1 (en) * 1998-08-12 2000-02-24 Edko Trading And Representation Company Limited Nimesulide containing topical pharmaceutical compositions
US6258816B1 (en) * 1997-11-06 2001-07-10 Panacea Biotec Limited Anti-allergy anti-inflammatory composition
WO2005087195A2 (en) * 2004-03-18 2005-09-22 Panacea Biotec Ltd. Novel compositions for topical delivery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2188007C2 (en) * 1998-10-27 2002-08-27 Панацея Биотек Лимитед New antiallergic antiphlogistic composition and method for its obtaining

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782855A1 (en) * 1994-10-05 1997-07-09 Helsinn Healthcare S.A. Antiinflammatory agent for external use
US6258816B1 (en) * 1997-11-06 2001-07-10 Panacea Biotec Limited Anti-allergy anti-inflammatory composition
WO2000009117A1 (en) * 1998-08-12 2000-02-24 Edko Trading And Representation Company Limited Nimesulide containing topical pharmaceutical compositions
WO2005087195A2 (en) * 2004-03-18 2005-09-22 Panacea Biotec Ltd. Novel compositions for topical delivery

Also Published As

Publication number Publication date
EA200702171A1 (en) 2008-04-28
WO2006105741A2 (en) 2006-10-12
CZ2005214A3 (en) 2006-10-11
CZ297215B6 (en) 2006-10-11
EP1879565A2 (en) 2008-01-23
WO2006105741B1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
WO2009072007A3 (en) Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP1589947B8 (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
DK1792927T3 (en) New block copolymer, micelle preparation and anticancer agent containing the same as active ingredient
WO2007086001A3 (en) Novel pyridine derivatives
WO2006091529A3 (en) A solid pharmaceutical dosage formulation
IL184288A0 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
WO2008003050A3 (en) Gallium nitrate formulations
IL195935A0 (en) 18-methyl-19-nor-androst-4-en 17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
WO2008142569A3 (en) Topical compositions containing magaldrate
WO2010052466A8 (en) Pharmaceutical aerosol composition
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
WO2006072070A3 (en) Pharmaceutical formulations of gallium salts
WO2007121471A3 (en) Dialkyl ether delivery agents
PL1795186T3 (en) Flupirtin comprising medicament formulation with a controlled release of the active agent
WO2006105741A3 (en) Topical pharmaceutical formulation containing nimesulide
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
ZA200805938B (en) Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant
EP1992349B8 (en) CGRP antagonists, their preparation and use as a medicament
WO2005097192A3 (en) Active substance combination of a carbinol compound and an opioid
AU2003228305A1 (en) Pharmaceutical composition with combined active agents and methods for using the same
WO2007022532A3 (en) Cyclopropyl compounds and compositions for delivering active agents
IL187419A0 (en) Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
TW200621304A (en) Pharmaceutical composition
陈钲红 et al. How Old Is the Table?

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2006705758

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

WWE Wipo information: entry into national phase

Ref document number: 200702171

Country of ref document: EA

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06705758

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 2006705758

Country of ref document: EP